Oncology
Peripheral T cell lymphoma treated by autologous transplantation
Published in Blood Weekly, August 17th, 2006
According to a study from the United States, "ASCT is the standard of care for chemosensitive relapsed or primary refractory aggressive lymphoma, but little is known about its efficacy in the subset of patients with PTCL. We undertook a retrospective review of patients with PTCL who underwent ASCT for relapsed or refractory disease after responding to second-line therapy, excluding patients with indolent histologies and those with anaplastic lymphoma kinase (ALK) expressing anaplastic large cell...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-08-17)
More Articles from Blood Weekly
- Artificial Liver
Solution preserves urea cycle enzymes in hepatocytes - Cardiovascular Research
Endotoxic shock-associated hemodynamics may be improved with large-pore membrane hemofiltration - Developmental Biology
Growth and osteogenic differentiation of bone marrow stromal cells characterized - Tissue Engineering
Skin preserved long-term in anhydric sodium chloride resumes function after transplantation - Alzheimer Disease
Exelon Patch, first transdermal therapy for Alzheimer disease, may provide new treatment approach - Angiology
Femoral arterial occlusive disease successfully treated with Hemobahn/Viabahn endoprostheses - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
